Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SDHA pseudogene 3 (SDHAP3) is a non-coding pseudogene in humans that shares sequence homology with SDHA, the succinate dehydrogenase complex flavoprotein subunit A gene, but does not produce a functional protein. Unlike the protein-coding SDHA gene, which is involved in mitochondrial energy metabolism and is implicated in several cancer syndromes and metabolic diseases, SDHAP3 lacks known biological function, disease relevance, signaling pathways, or therapeutic interactions. It is located on chromosome 5 and has previously been referred to by aliases such as SDHAL and SDHACL. SDHAP3 is included in genomic databases to help distinguish it from the functional SDHA sequence and prevent misinterpretation in gene targeting or expression analyses. Researchers must be careful not to confuse SDHAP3 with SDHA in experimental designs and drug discovery applications[5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SDHA pseudogene 3 (SDHAP3).